Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2008289573 (hide)

Owner Merck & Co., Inc.

Inventors Qian, Xiaoxia; Biftu, Tesfaye; Feng, Danqing; Xu, Jinyou; Weber, Ann E.; Cox, Jason M.

Agent Spruson & Ferguson

Pub. Number AU-A-2008289573

PCT Pub. Number WO2009/025784

Priority 60/965,562 21.08.07 US

Filing date 18 August 2008

Wipo publication date 26 February 2009

International Classifications

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/67 (2006.01) - having sulfur as a ring hetero atom

Event Publications

4 February 2010 PCT application entered the National Phase

  PCT publication WO2009/025784 Priority application(s): WO2009/025784

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008289583-RFID antenna for use adjacent to conductive elements

2008289571-Hemostatic agent composition and method of delivery